503 related articles for article (PubMed ID: 26813288)
21. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
Kim YJ; Yoon HY; Kim SK; Kim YW; Kim EJ; Kim IY; Kim WJ
Clin Cancer Res; 2011 Jul; 17(13):4523-30. PubMed ID: 21571867
[TBL] [Abstract][Full Text] [Related]
22. Orphan CpG islands define a novel class of highly active enhancers.
Bell JSK; Vertino PM
Epigenetics; 2017 Jun; 12(6):449-464. PubMed ID: 28448736
[TBL] [Abstract][Full Text] [Related]
23. Analyzing DNA Methylation Patterns During Tumor Evolution.
Pan H; Elemento O
Methods Mol Biol; 2018; 1711():27-53. PubMed ID: 29344884
[TBL] [Abstract][Full Text] [Related]
24. Predicting aberrant CpG island methylation.
Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846
[TBL] [Abstract][Full Text] [Related]
25. Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer.
Bae MG; Kim JY; Choi JK
BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):38. PubMed ID: 27534853
[TBL] [Abstract][Full Text] [Related]
26. Targeted bisulfite sequencing: A novel tool for the assessment of DNA methylation with high sensitivity and increased coverage.
Moser DA; Müller S; Hummel EM; Limberg AS; Dieckmann L; Frach L; Pakusch J; Flasbeck V; Brüne M; Beygo J; Klein-Hitpass L; Kumsta R
Psychoneuroendocrinology; 2020 Oct; 120():104784. PubMed ID: 32673938
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation markers in colorectal cancer.
Kim MS; Lee J; Sidransky D
Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
[TBL] [Abstract][Full Text] [Related]
28. Reduced representation bisulfite sequencing to identify global alteration of DNA methylation.
Nagarajan A; Roden C; Wajapeyee N
Methods Mol Biol; 2014; 1176():23-31. PubMed ID: 25030916
[TBL] [Abstract][Full Text] [Related]
29. Conservation and divergence of DNA methylation in eukaryotes: new insights from single base-resolution DNA methylomes.
Su Z; Han L; Zhao Z
Epigenetics; 2011 Feb; 6(2):134-40. PubMed ID: 20962593
[TBL] [Abstract][Full Text] [Related]
30. Using epigenomics data to predict gene expression in lung cancer.
Li J; Ching T; Huang S; Garmire LX
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S10. PubMed ID: 25861082
[TBL] [Abstract][Full Text] [Related]
31. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.
Harten SK; Oey H; Bourke LM; Bharti V; Isbel L; Daxinger L; Faou P; Robertson N; Matthews JM; Whitelaw E
BMC Biol; 2015 Mar; 13():21. PubMed ID: 25857663
[TBL] [Abstract][Full Text] [Related]
32. A comparison of existing global DNA methylation assays to low-coverage whole-genome bisulfite sequencing for epidemiological studies.
Crary-Dooley FK; Tam ME; Dunaway KW; Hertz-Picciotto I; Schmidt RJ; LaSalle JM
Epigenetics; 2017 Mar; 12(3):206-214. PubMed ID: 28055307
[TBL] [Abstract][Full Text] [Related]
33. Unmasking risk loci: DNA methylation illuminates the biology of cancer predisposition: analyzing DNA methylation of transcriptional enhancers reveals missed regulatory links between cancer risk loci and genes.
Aran D; Hellman A
Bioessays; 2014 Feb; 36(2):184-90. PubMed ID: 24277586
[TBL] [Abstract][Full Text] [Related]
34. CpG traffic lights are markers of regulatory regions in human genome.
Lioznova AV; Khamis AM; Artemov AV; Besedina E; Ramensky V; Bajic VB; Kulakovskiy IV; Medvedeva YA
BMC Genomics; 2019 Feb; 20(1):102. PubMed ID: 30709331
[TBL] [Abstract][Full Text] [Related]
35. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
[TBL] [Abstract][Full Text] [Related]
36. Changes in correlation between promoter methylation and gene expression in cancer.
Moarii M; Boeva V; Vert JP; Reyal F
BMC Genomics; 2015 Oct; 16():873. PubMed ID: 26510534
[TBL] [Abstract][Full Text] [Related]
37. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
38. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
39. Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers.
Stueve TR; Li WQ; Shi J; Marconett CN; Zhang T; Yang C; Mullen D; Yan C; Wheeler W; Hua X; Zhou B; Borok Z; Caporaso NE; Pesatori AC; Duan J; Laird-Offringa IA; Landi MT
Hum Mol Genet; 2017 Aug; 26(15):3014-3027. PubMed ID: 28854564
[TBL] [Abstract][Full Text] [Related]
40. Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation.
Yamada Y; Nishida T; Horibe H; Oguri M; Kato K; Sawabe M
Int J Mol Med; 2014 May; 33(5):1355-63. PubMed ID: 24626634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
